Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$566M |
| 2 |
Meta Platforms (Facebook)
META
|
+$401M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$366M |
| 4 |
Align Technology
ALGN
|
+$356M |
| 5 |
PayPal
PYPL
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$564M |
| 2 |
Alibaba
BABA
|
+$511M |
| 3 |
Altria Group
MO
|
+$439M |
| 4 |
Revvity
RVTY
|
+$321M |
| 5 |
Merck
MRK
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.77% |
| 2 | Healthcare | 19.73% |
| 3 | Consumer Discretionary | 11.5% |
| 4 | Financials | 9.61% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Intercontinental Exchange
ICE
$87.2B
| $112M | 0.06% |
1,116,216
-39,101
| -3% | -$3.85M |
|
302
Keysight
KEYS
$50.7B
| $111M | 0.06% |
1,120,784
+176,006
| +19% | +$17.3M |
|
303
Seagate
STX
$173B
| $111M | 0.06% |
2,245,119
+723,877
| +48% | +$34M |
|
304
Teck Resources
TECK
$28.2B
| $111M | 0.06% |
7,964,492
+682,150
| +9% | +$8.08M |
|
305
Ball Corp
BALL
$17.5B
| $111M | 0.06% |
1,329,985
-59,691
| -4% | -$4.59M |
|
|
SGEN
306
DELISTED
Seagen Inc. Common Stock
SGEN
| $109M | 0.06% |
557,785
+212,216
| +61% | +$35.5M |
|
|
AKRO
307
DELISTED
Akero Therapeutics
AKRO
| $109M | 0.06% |
3,535,455
+796,937
| +29% | +$27.9M |
|
308
National Vision
EYE
$1.76B
| $108M | 0.06% |
2,825,074
+153,535
| +6% | +$5.34M |
|
309
Exelixis
EXEL
$13.9B
| $108M | 0.06% |
4,410,094
-893,989
| -17% | -$20.9M |
|
310
Xcel Energy
XEL
$49.2B
| $107M | 0.06% |
1,548,653
-183,788
| -11% | -$12.5M |
|
311
Collegium Pharmaceutical
COLL
$1.18B
| $107M | 0.06% |
5,122,359
-14,126
| -0.3% | -$255K |
|
312
T. Rowe Price
TROW
$25.5B
| $107M | 0.06% |
830,824
+212,765
| +34% | +$28.1M |
|
313
Hartford Financial Services
HIG
$39.9B
| $106M | 0.06% |
2,889,023
+233,302
| +9% | +$9.3M |
|
314
EnerSys
ENS
$6.43B
| $106M | 0.06% |
1,585,150
+4,544
| +0.3% | +$312K |
|
315
Cardinal Health
CAH
$53.7B
| $106M | 0.06% |
2,264,394
+831,336
| +58% | +$42.7M |
|
316
Dominion Energy
D
$62B
| $106M | 0.06% |
1,344,849
+414,767
| +45% | +$32.6M |
|
317
UBS Group
UBS
$170B
| $105M | 0.05% |
9,354,887
+131,773
| +1% | +$1.58M |
|
318
Micron Technology
MU
$835B
| $104M | 0.05% |
2,211,185
-3,554,983
| -62% | -$172M |
|
319
Campbell Soup
CPB
$6.85B
| $103M | 0.05% |
2,130,002
+418,211
| +24% | +$20.6M |
|
320
Otis Worldwide
OTIS
$27.9B
| $101M | 0.05% |
1,620,126
+389,708
| +32% | +$23.8M |
|
321
Icon
ICLR
$13.7B
| $101M | 0.05% |
528,339
-30,554
| -5% | -$5.62M |
|
322
Carter's
CRI
$1.43B
| $101M | 0.05% |
1,162,750
+11,673
| +1% | +$972K |
|
323
Amphenol
APH
$185B
| $100M | 0.05% |
3,701,644
-2,536,984
| -41% | -$66.9M |
|
324
Unifirst Corp
UNF
$5.45B
| $100M | 0.05% |
528,228
-28,434
| -5% | -$5.32M |
|
|
SAIL
325
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $99.9M | 0.05% |
2,524,619
-452,834
| -15% | -$15.7M |
|
Similar funds
Janus Henderson Group's Q3 2020 Portfolio in Review
As of Q3 2020, Janus Henderson Group held 1,403 positions worth $192B, up 7.7% from $178B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q3 2020 filing shows 105 new, 521 increased, 678 reduced and 86 closed positions. Its largest new stake was Acceleron Pharma: 1,783,939 shares worth $201M. The largest sale was Apple, an estimated $564M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2020 buy was Acceleron Pharma: 1,783,939 shares worth $201M.
- Janus Henderson Group added most to Booking.com in Q3 2020, an estimated $566M increase.
- Janus Henderson Group's biggest Q3 2020 reduction was Apple, cutting an estimated $564M.
- Janus Henderson Group fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $49.5M.
- Janus Henderson Group's ten largest holdings make up 24% of its $192B portfolio in Q3 2020.
- Janus Henderson Group opened 105 new positions and closed 86 in Q3 2020.
- Janus Henderson Group's portfolio value rose 7.7% quarter-over-quarter to $192B.
Based on Janus Henderson Group's 13F filing for Q3 2020, filed 16 Nov 2020.